AddLife AB (publ) (ALIF-B.ST) has a MoatMap StockRank of 53/100 based on Quality (59/100), Value (37/100), and Momentum (43/100) factor scores. The current signal is HOLD. AddLife is a high-quality Swedish life sciences distributor that operates a successful decentralized serial acquisition model. While it has strong compounder characteristics and high ROIC, it lacks direct alignment with our specific 18-month macro themes (such as CDMO pricing power or advanced packaging) to warrant an immediate high-conviction buy.
AddLife AB (publ) is an independent distributor of high-quality products, services, and advice to the life science sector, primarily in Northern Europe. AddLife's competitive advantage lies in its broad product portfolio, strong supplier relationships, deep industry knowledge, and established distribution channels. It acts as a specialized niche player, connecting leading suppliers with healthcare and research institutions.
| Price | $17.14 |
| Market Cap | $2.0B |
| P/E (TTM) | 34.13 |
| P/E (Forward) | 49.91 |
| Price/Book | 3.42 |
| Return on Equity | 10.6% |
| Return on Invested Capital | 11.2% |
| Debt/Equity | 85.10 |
| Gross Margin | 38.3% |
| Operating Margin | 8.7% |
| Revenue Growth | -2.1% |
| Dividend Yield | 1.0% |
| Free Cash Flow | $9M |
AddLife AB (publ) operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (Sweden).